Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Innospec (IOSP) stocks in Canada

Learn how to easily invest in Innospec stocks.

Innospec is a specialty chemicals business based in the US. Innospec stocks (IOSP.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $88.88 – a decrease of 1.4% over the previous week. Innospec employs 1,900 staff and has a trailing 12-month revenue of around $1.4 billion.

How to buy shares in Innospec

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – IOSP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Innospec stock price (NASDAQ:IOSP)

Use our graph to track the performance of IOSP stocks over time.

Innospec shares at a glance

Information last updated 2022-01-25.
Latest market close$93.07
52-week range$80.53 - $106.47
50-day moving average $90.90
200-day moving average $92.21
Wall St. target price$112.00
PE ratio 25.7267
Dividend yield $1.09 (1.25%)
Earnings per share (TTM) $3.69

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Innospec stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Innospec price performance over time

Historical closes compared with the close of $93.07 from 2022-01-27

1 week (2022-01-21) -1.40%
1 month (2021-12-29) 1.24%
3 months (2021-10-29) 2.71%
6 months (2021-07-29) 4.68%
1 year (2021-01-29) 6.01%
2 years (2020-01-29) -10.54%
3 years (2019-01-29) 35.39%
5 years (2017-01-27) 28.91%

Is Innospec under- or over-valued?

Valuing Innospec stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Innospec's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Innospec's P/E ratio

Innospec's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 26x. In other words, Innospec shares trade at around 26x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Innospec's EBITDA

Innospec's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $172.4 million.

The EBITDA is a measure of a Innospec's overall financial performance and is widely used to measure a its profitability.

Innospec financials

Revenue TTM $1.4 billion
Operating margin TTM 9.5%
Gross profit TTM $342.7 million
Return on assets TTM 5.78%
Return on equity TTM 9.57%
Profit margin 6.65%
Book value $40.27
Market capitalisation $2.3 billion

TTM: trailing 12 months

Innospec share dividends


Dividend payout ratio: 24.27% of net profits

Recently Innospec has paid out, on average, around 24.27% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.25% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Innospec shareholders could enjoy a 1.25% return on their shares, in the form of dividend payments. In Innospec's case, that would currently equate to about $1.09 per share.

While Innospec's payout ratio might seem low, this can signify that Innospec is investing more in its future growth.

Innospec's most recent dividend payout was on 23 November 2021. The latest dividend was paid out to all shareholders who bought their shares by 14 November 2021 (the "ex-dividend date").

Have Innospec's shares ever split?

Innospec's shares were split on a 2:1 basis on 22 July 2007. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Innospec shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Innospec shares which in turn could have impacted Innospec's share price.

Innospec share price volatility

Over the last 12 months, Innospec's shares have ranged in value from as little as $80.5301 up to $106.4709. A popular way to gauge a stock's volatility is its "beta".

IOSP.US volatility(beta: 1.36)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Innospec's is 1.3644. This would suggest that Innospec's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Innospec overview

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. It operates through Fuel Specialties, Performance Chemicals, and Oilfield Services segments. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. Its products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. The Performance Chemicals segment provides technology-based solutions for its customers' processes or products focused in the personal care, home care, agrochemical, and metal extraction markets. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations; chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, which enable flow assurance and maintain asset integrity.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site